Target intelligence / Profile preview

Rho guanine nucleotide exchange factor 7 (ARHGEF7) (ARHGEF7)

Target
ARHGEF7
Molecular classification
Guanine nucleotide exchange factor, Rho GEF
01

Overview

Rho guanine nucleotide exchange factor 7 (ARHGEF7), commonly referred to as Beta-PIX or COOL-1, is a multidomain protein that functions as a specific guanine nucleotide exchange factor for the Rho-family GTPases Rac1 and Cdc42 (UniProt: Q14155). By facilitating the transition of these GTPases from an inactive GDP-bound state to an active GTP-bound state, ARHGEF7 plays a pivotal role in regulating actin cytoskeleton remodeling, focal adhesion dynamics, and cellular morphology (PubMed: 25659585). In clinical oncology, ARHGEF7 is frequently overexpressed in various malignancies, such as glioblastoma and breast cancer, where it promotes tumor cell proliferation, invasion, and metastasis (PubMed: 30217959). Targeting the ARHGEF7 mRNA through RNA interference (RNAi) or antisense oligonucleotides is an active area of research aimed at downregulating protein expression to inhibit these oncogenic processes. Beyond its role in cancer, ARHGEF7 is essential for neuronal development and synaptic plasticity, and its dysfunction has been linked to neurodevelopmental disorders (NCBI Gene: 8874). Consequently, therapeutic strategies must carefully address the potential for off-target effects and the disruption of normal physiological functions mediated by this protein.

Other names
Beta-PIXCOOL-1PAK3BPSH3BP1p85SPRCOOL1
02

Mechanism of action

RNA interference (RNAi) mediated degradation of mRNA leading to decreased protein synthesis.

03

Biological functions

Signal transductionCytoskeleton organizationCell migrationCell proliferationSynaptic plasticity
04

Disease associations

CancerGlioblastomaBreast cancerColorectal cancerNeurological disease
05

Safety considerations

Off-target effects of RNA-based therapeuticsImpairment of normal cell motilityPotential neurotoxicity due to role in synaptic plasticity
06

Interacting drugs

Experimental siRNA

1 more in the full profile.

07

Biomarkers

ARHGEF7 mRNA expression levelARHGEF7 protein expression level

Beyond the preview

Go deeper on Rho guanine nucleotide exchange factor 7 (ARHGEF7) (ARHGEF7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rho guanine nucleotide exchange factor 7 (ARHGEF7) (ARHGEF7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call